Pharma-X Inc
Pharma-X Inc
  • Home
  • About Us
  • Our Services
  • Our Team
  • Contact Us
  • More
    • Home
    • About Us
    • Our Services
    • Our Team
    • Contact Us

  • Home
  • About Us
  • Our Services
  • Our Team
  • Contact Us

About Us

Our Mission

We engineer and operate state-of-the-art fill-finish solutions that combine deep scientific expertise, rigorous quality, and agile project management, enabling our clients to deliver sterile medicines safely, efficiently, and reliably to patients worldwide. 

Our Vision

To become the world’s most advanced, multi-use aseptic CDMO—empowering innovators to move lifesaving therapies through the pipeline faster through unmatched flexibility, accountability, and transparent partnership.

Positioning for Tomorrow

With world-class infrastructure, deep scientific expertise, and a client-centric culture, Pharma-X is poised to become the CDMO partner of choice for innovators seeking reliable, compliant, and agile sterile manufacturing services across North America and beyond. 

Quality and Compliance

 At Pharma-X, quality is engineered into every blueprint, decision, and data point from the ground up. Our new manufacturing facility is designed to meet and exceed Health Canada, FDA, EMA, and other global regulatory expectations. A single enterprise-wide QMS allows inspection readiness from the very first batch. Robust supplier-qualification programs, built-in real-time release testing, and an ALCOA+ data-integrity architecture safeguards every lot, while our client portal will offer full transparency throughout the product lifecycle. The result: unwavering compliance and the confidence that each future dose will consistently meet the highest international standards. 

Contact Us

Copyright © 2025 Pharma-X Inc - All Rights Reserved.

Powered by

  • Home
  • About Us
  • Our Services
  • Our Team
  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept